| Date Filed | Type | Description |
| 02/14/2020 |
SC 13G/A
| Redmile Group, LLC reports a 0% stake in Nightstar Therapeutics plc |
| 02/04/2020 |
SC 13G/A
| Woodford Investment Management LLP reports a 0% stake in Nightstar Therapeutics plc |
| 06/17/2019 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 06/12/2019 |
SC 13D/A
| New Enterprise Associates 15, L.P. has filed a Schedule 13D for Nightstar Therapeutics plc |
| 06/11/2019 |
4
| Syncona Portfolio Ltd (10% Owner) has filed a Form 4 on Nightstar Therapeutics plc|
Txns:
| Disposed/sold 13,203,922 shares
@ $25.5, valued at
$336.7M
|
|
| 06/10/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 06/10/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 06/10/2019 |
8-K
| Quarterly results |
| 06/07/2019 |
4
| MOTT DAVID M (10% Owner) has filed a Form 4 on Nightstar Therapeutics plc|
Txns:
| Disposed/sold 6,662,532 shares
@ $25.5, valued at
$169.9M
Disposed/sold 36,400 options to buy
@ $12.27, valued at
$446.6k
Disposed/sold 21,000 options to buy
@ $13.57, valued at
$285k
|
|
| 06/07/2019 |
4
| New Enterprise Associates 15, L.P. (10% Owner) has filed a Form 4 on Nightstar Therapeutics plc|
Txns:
| Disposed/sold 6,662,532 shares
@ $25.5, valued at
$169.9M
|
|
| 06/07/2019 |
4
| Yoon Seokho Bryan (General Counsel and Secretary) has filed a Form 4 on Nightstar Therapeutics plc|
Txns:
| Disposed/sold 160,000 options to buy
@ $22.78, valued at
$3.6M
Disposed/sold 15,000 options to buy
@ $14.24, valued at
$213.6k
Disposed/sold 85,100 options to buy
@ $14.74, valued at
$1.3M
|
|
| 06/07/2019 |
4
| Whitcup Scott M (Director) has filed a Form 4 on Nightstar Therapeutics plc|
Txns:
| Disposed/sold 74,568 shares
@ $25.5, valued at
$1.9M
Disposed/sold 18,200 options to buy
@ $12.27, valued at
$223.3k
Disposed/sold 21,000 options to buy
@ $13.57, valued at
$285k
|
|
| 06/07/2019 |
4
| Sundaram Senthil Vel (CFO) has filed a Form 4 on Nightstar Therapeutics plc|
Txns:
| Disposed/sold 126,886 shares
@ $25.5, valued at
$3.2M
Disposed/sold 60,000 options to buy
@ $14.24, valued at
$854.4k
Disposed/sold 108,700 options to buy
@ $14.74, valued at
$1.6M
|
|
| 06/07/2019 |
4
| Robinson Gregory Scott (Chief Scientific Officer) has filed a Form 4 on Nightstar Therapeutics plc|
Txns:
| Disposed/sold 103,182 shares
@ $25.5, valued at
$2.6M
Disposed/sold 75,000 options to buy
@ $14.24, valued at
$1.1M
Disposed/sold 91,400 options to buy
@ $14.74, valued at
$1.3M
|
|
| 06/07/2019 |
4
| Ong Tuyen (Chief Development Officer) has filed a Form 4 on Nightstar Therapeutics plc|
Txns:
| Disposed/sold 80,479 shares
@ $25.5, valued at
$2.1M
Disposed/sold 37,500 options to buy
@ $14.24, valued at
$534k
Disposed/sold 97,400 options to buy
@ $14.74, valued at
$1.4M
|
|
| 06/07/2019 |
4
| McArthur James G (Director) has filed a Form 4 on Nightstar Therapeutics plc|
Txns:
| Disposed/sold 37,237 shares
@ $25.5, valued at
$949.5k
Disposed/sold 18,200 options to buy
@ $12.27, valued at
$223.3k
Disposed/sold 21,000 options to buy
@ $13.57, valued at
$285k
|
|
| 06/07/2019 |
4
| Lubner David Charles (Director) has filed a Form 4 on Nightstar Therapeutics plc|
Txns:
| Disposed/sold 29,124 shares
@ $25.5, valued at
$742.7k
Disposed/sold 18,200 options to buy
@ $12.27, valued at
$223.3k
Disposed/sold 21,000 options to buy
@ $13.57, valued at
$285k
|
|
| 06/07/2019 |
4
| Hollowood Christopher J (Director) has filed a Form 4 on Nightstar Therapeutics plc|
Txns:
| Disposed/sold 13,203,922 shares
@ $25.5, valued at
$336.7M
Disposed/sold 36,400 options to buy
@ $12.27, valued at
$446.6k
Disposed/sold 21,000 options to buy
@ $13.57, valued at
$285k
|
|
| 06/07/2019 |
4
| FELLOWS DAVID A (CEO) has filed a Form 4 on Nightstar Therapeutics plc|
Txns:
| Disposed/sold 617,090 shares
@ $25.5, valued at
$15.7M
Disposed/sold 220,000 options to buy
@ $14.24, valued at
$3.1M
Disposed/sold 271,100 options to buy
@ $14.74, valued at
$4M
|
|
| 06/07/2019 |
4
| Cobb Paula K (Director) has filed a Form 4 on Nightstar Therapeutics plc|
Txns:
| Disposed/sold 36,400 options to buy
@ $25.16, valued at
$915.8k
Disposed/sold 21,000 options to buy
@ $13.57, valued at
$285k
|
|
| 06/07/2019 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 05/29/2019 |
8-K
| Other Events, Financial Statements and Exhibits |
| 05/09/2019 |
10-Q
| Quarterly Report for the period ended March 31, 2019 |
| 05/08/2019 |
8-K
| Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits |
| 04/30/2019 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/30/2019 |
10-K/A
| Annual Report for the period ended December 31, 2018 [amend] |
| 04/26/2019 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/25/2019 |
SC 13D
| Polygon Global Partners LLP reports a 8% stake in Nightstar Therapeutics plc |
| 04/16/2019 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/10/2019 |
SC 13G/A
| WELLINGTON MANAGEMENT GROUP LLP reports a 0% stake in Nightstar Therapeutics plc |
| 04/09/2019 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/09/2019 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition: |
| 04/03/2019 |
4
| Sundaram Senthil Vel (CFO) has filed a Form 4 on Nightstar Therapeutics plc|
Txns:
| Sold 391 shares
@ $25.31, valued at
$9.9k
|
|
| 04/03/2019 |
4
| Robinson Gregory Scott (Chief Scientific Officer) has filed a Form 4 on Nightstar Therapeutics plc|
Txns:
| Sold 410 shares
@ $25.31, valued at
$10.4k
|
|
|